← Scroll for more →
Financial Statements — PHVS
Balance Sheet
(in millions EUR)| Metric | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 291.68 | 199.57 | 280.73 | 343.57 | 391.23 | 179.19 | 161.84 | 201.38 | 209.35 |
| Total Assets | 301.45 | 209.81 | 291.37 | 351.85 | 398.69 | 189.74 | 167.73 | 206.74 | 212.09 |
| Total Liabilities | 30.18 | 25.47 | 23.61 | 19.08 | 14.65 | 16.01 | 18.47 | 16.17 | 7.14 |
| Retained Earnings | (579.60) | (494.94) | (402.26) | (324.77) | (265.92) | (208.86) | (164.19) | (116.24) | (87.57) |
| Total Stockholder Equity | 271.27 | 184.34 | 267.76 | 332.77 | 384.05 | 173.73 | 149.26 | 190.57 | 204.95 |
← Scroll for more columns →
Income Statement
(in millions EUR) (except per-share rows)| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Research & Development | 29.61 | 23.07 | 14.68 | 13.72 |
| Selling, General & Admin | 10.77 | 11.31 | 7.77 | 7.66 |
| Total Operating Expenses | 40.37 | 34.38 | 22.46 | 21.38 |
| Operating Income | (45.28) | (29.66) | (21.80) | (9.88) |
| Pretax Income | (91.32) | (57.39) | (44.37) | (25.87) |
| Tax Provision | 0.20 | 0.07 | 0.09 | 2.74 |
| Net Income | (45.48) | (29.73) | (21.90) | (12.62) |
| Basic EPS | (0.83) | (0.55) | (0.63) | (0.38) |
| Diluted EPS | (0.83) | (0.55) | (0.63) | (0.38) |
← Scroll for more columns →
Cash Flow Statement
(in millions EUR)| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Operating Cash Flow | (68.45) | (51.91) | (45.69) | (31.57) |
| Investing Cash Flow | (0.14) | (0.07) | (0.05) | (0.05) |
| Financing Cash Flow | (0.10) | 1.12 | 63.78 | 8.82 |
← Scroll for more columns →